EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment

Manish Kumar Singh iD, Sunhee Han, Sungsoo Kim iD, Insug Kang iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252011185 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Manish Kumar Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Lipid Metabolism, Neoplasms, Autophagy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs), or tumor-initiating cells (TICs), are small subpopulations (0.0001–0.1%) of cancer cells that are crucial for cancer relapse and therapy resistance. The elimination of each CSC is essential for achieving long-term remission. Metabolic reprogramming, particularly lipids, has a significant impact on drug efficacy by influencing drug diffusion, altering membrane permeability, modifying mitochondrial function, and adjusting the lipid composition within CSCs. These changes contribute to the development of chemoresistance in various cancers. The intricate relationship between lipid metabolism and drug resistance in CSCs is an emerging area of research, as different lipid species play essential roles in multiple stages of autophagy. However, the link between autophagy and lipid metabolism in the context of CSC regulation remains unclear. Understanding the interplay between autophagy and lipid reprogramming in CSCs could lead to the development of new approaches for enhancing therapies and reducing tumorigenicity in these cells. In this review, we explore the latest findings on lipid metabolism in CSCs, including the role of key regulatory enzymes, inhibitors, and the contribution of autophagy in maintaining lipid homeostasis. These recent findings may provide critical insights for identifying novel pharmacological targets for effective anticancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsLipid MetabolismNeoplasmsAutophagyAntineoplastic AgentsHumansAnimalsDrug Resistance, Neoplasm

Stichwörter der Autor:innen

autophagycancer stem celldrug resistancelipidsstemnesstumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Biomedical Science Institute, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.

ORCID-Profile: Manish Kumar Singh, Sungsoo Kim, Insug Kang

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Singh, M. K., Han, S., Kim, S., & Kang, I. (2024). Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011185

Vancouver

Singh MK, Han S, Kim S, Kang I. Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011185

BibTeX
@article{Singh2024,
  author = {Singh, Manish Kumar and Han, Sunhee and Kim, Sungsoo and Kang, Insug},
  title = {Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252011185}
}
Kostenlos starten →